MET vs UNM: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. MET and UNM share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined MET and UNM exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

MetLife, Inc. is one of the world's largest providers of life insurance, employee benefits, annuities, and asset management, serving individuals and institutional clients across the United States, Asia, Latin America, Europe, the Middle East, and Africa. It reports through several segments, including Group Benefits (group life, dental, disability, and other workplace coverage), Retirement and Income Solutions (annuities, pension risk transfers, structured settlements, and stable value products), Asia, Latin America, EMEA, and MetLife Holdings, its book of legacy US business. The core model is classic insurance: collect premiums, pay claims and benefits over time, and invest the difference (the float) in a large fixed-income-heavy portfolio, earning a spread. That makes MetLife both an underwriter and a giant investor, so its profitability depends on disciplined pricing, mortality and morbidity trends, and the returns it earns on invested assets.

Full MET guide

Unum Group is a Chattanooga, Tennessee based insurance holding company that sells group and voluntary employee benefits, with a core focus on long-term and short-term disability, group life, accidental death, dental, and supplemental products distributed largely through employers. It operates through several segments including Unum US, Colonial Life (voluntary benefits sold at the worksite), Unum International (mainly the UK and Poland), and a Closed Block that houses legacy long-term-care and individual disability policies in runoff. It is widely described as the leading provider of workplace disability coverage in the United States, generating the bulk of its premium from employer-sponsored plans.

Full UNM guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• MET drivers: Group Benefits and workplace demand; Retirement and Income Solutions.
• UNM drivers: Leading position in workplace disability and voluntary benefits; High return on equity and strong capital return.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: MetLife's biggest risks come from the same levers that drive its profits. For UNM, unum's earnings are sensitive to the economy and employment, since rising unemployment can both lower covered payrolls and increase disability and leave claims.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick MET if you believe its drivers more; UNM if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the MET and UNM guides.

MET. These are qualitative and approximate as of the asOf date and not precise real-time figures. Insurer results are heavily affected by interest rates, credit markets, and actuarial assumption changes, so reported numbers can differ sharply from adjusted ones. Confirm live revenue, EPS, dividend, and valuation before acting.

UNM. Unum trades at a below-market earnings multiple typical of insurers, reflecting its value-and-income profile and the historical discount tied to legacy long-term-care exposure. The roughly 20 percent adjusted operating return on equity and consistent capital return are the main supports for the valuation, while reserve adequacy and employment trends are the swing factors.

Headline figures (approximate, Jul 2026): MET shows revenue trend Full-year 2025 revenue was about $77.1 billion, up mid-single digits year over year; Q1 2026 revenue was roughly $19 billion, profitability Adjusted EPS has been rising (Q1 2026 adjusted EPS ~$2.42, up ~23% year over year), while reported net income can swing on investment and actuarial items, balance sheet / leverage Large, mostly fixed-income investment portfolio backing long-duration liabilities; capital-intensive and regulated, with statutory capital and ratings constraints, capital returns Raised the quarterly dividend ~4.4% to $0.5925 per share in 2026 and extended buybacks; targets $25 billion-plus of free cash flow over its plan; UNM shows market cap ~$14.4B, revenue (fy2025) ~$13.1B, net income (fy2025, gaap) ~$642M, adjusted operating eps (fy2025) ~$8.13.

MET and UNM are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined MET and UNM exposure against your real portfolio. It is not an investment adviser.